Brief: Virpax Pharmaceuticals Announces Preliminary Results Of Probudurtm Pilot Study With The U.S. Army Institute Of Surgical Research
07/02/2024 12:42
Feb 7 (Reuters) - Virpax Pharmaceuticals Inc VRPX.O :
* VIRPAX PHARMACEUTICALS ANNOUNCES PRELIMINARY RESULTS OF
PROBUDURTM PILOT STUDY WITH THE U.S. ARMY INSTITUTE OF SURGICAL
RESEARCH
Source text for Eikon: ID:nBw5F4xHWa
Further company coverage: VRPX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Virpax Pharmaceuticals
See all newsVirpax Pharma plunges as Nasdaq delisting looms
Brief: Virpax Pharmaceuticals Files For Offering On Best Efforts Basis Up To 2.4 Million Shares Of Common Stock
Brief: Virpax receives positive Probudur™ results for dose range study
Brief: Virpax Looking To Use Met To Develop Intranasal Covid Vaccine
Brief: Virpax Confirms Positive Results With Us Army With Probudur™ For Combat Care Study